Abivax (ABVX) PT Raised to $115 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Thomas Smith raised the price target on Abivax (NASDAQ: ABVX) to $115.00 (from $104.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
